HJHua Jiang

Hua Jiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hua Jiang has a total of 130 co-authors. Here are the top co-authors by number of shared publications:

  • Qingqing Li

    Department of Geriatrics, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China; Department of Geriatrics, Shanghai Oriental Clinical Medical School of Nanjing Medical University, Shanghai 200120, China

    16 shared publications
  • Shasha Geng

    Department of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China

    15 shared publications
  • Xin Chen

    Department of Geriatrics, Shanghai East Hospital, Tongji University School of Medicine

    14 shared publications
  • Yingqian Zhu

    Department of Geriatrics, Shanghai East Hospital, Tongji University School of Medicine

    13 shared publications
  • Jianli Ge

    Department of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China

    11 shared publications
  • Yang Li

    Department of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China

    11 shared publications

Latest Publications

  • Open Access

    Associations of C‐Reactive Protein‐Triglyceride Glucose Index and Estimated Pulse Wave Velocity With All‐Cause Mortality: A Nationwide Prospective Cohort Study

    by Huixiao Yuan, Qingqing Li, Lei Sun, Jianli Ge, Shasha Geng, Xin Chen, Yingqian Zhu, Hua Jiang, Yang Li

    Background and Aims: The combined prognostic value of metaflammation and vascular aging markers in cardiovascular‐kidney‐metabolic (CKM) syndrome is unclear. This study aimed to assess the independent and joint associations of the C‐reactive protein‐triglyceride glucose index (CTI) and estimated pulse wave velocity (ePWV) with all‐cause mortality. Methods: This prospective study included 7183 participants from the CHARLS 2011 survey (original cohort) and 9594 from 2015 (temporal sensitivity analysis cohort). Multivariable Cox models and restricted cubic splines were used. Joint effects were analyzed by median‐based groups, and mediation was tested using the KHB method. Results: During follow‐up, 906 deaths occurred in the original cohort. Each 1‐unit increase in CTI was associated with a 56% higher mortality risk (HR = 1.56, 95% CI: 1.37–1.77), and each 1 m/s increase in ePWV with an 11% higher risk (HR = 1.11, 95% CI: 1.05–1.18). The high CTI/high ePWV group had the highest risk (HR = 1.73, 95% CI: 1.31–2.29). ePWV mediated 6.48% of the CTI‐mortality association, while CTI mediated 2.62% of the ePWV‐mortality association. These findings were confirmed in the temporal sensitivity analysis. Conclusion: CTI and ePWV independently and jointly associate with increased all‐cause mortality. The observed bidirectional mediation suggests potentially interconnected pathways that warrant further investigation. Integrating these accessible biomarkers could improve risk stratification in CKM syndrome.

  • Open Access

    Correction: Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty

    by Ce Huang, Yingqian Zhu, Xue Gong, Shengyu Feng, Guangying Huo, Hailiang Liu, Hua Jiang, Zhongmin Liu

  • Open Access

    Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty

    by Ce Huang, Yingqian Zhu, Xue Gong, Shengyu Feng, Guangying Huo, Hailiang Liu, Hua Jiang, Zhongmin Liu

    Background: Frailty associated with aging, characterized by chronic inflammation and immune dysfunction, poses a significant public health challenge. Human umbilical cord-derived mesenchymal stem cells (HUC-MSCs) exhibit immunomodulatory properties; however, their mechanism of action in frail elderly populations remains unclear. Building on a prior clinical trial investigating HUC-MSCs for elderly frailty (Trial Registration: ClinicalTrials.gov, NCT04314011; PubMed ID: 38679727), this study was conducted to further elucidate the mechanism of action of HUC-MSCs. Methods: We performed a longitudinal single-cell RNA sequencing (scRNA-seq) study on peripheral blood mononuclear cells (PBMCs) from frail elderly patients before and after HUC-MSCs therapy. Immune cell dynamics were analyzed across multiple time points, and cell-cell communication networks were reconstructed. Spearman correlation analyses were performed to link immune changes with clinical frailty and physical performance metrics. Results: HUC-MSCs induced a time-dependent recalibration of the immune system. An early, transient expansion of MAIT cells (p=0.049) was followed by a sustained reduction in B cell hyperactivity (p=0.032) and a phenotypic shift in naïve B cells. NK cell cytotoxicity was enhanced (increased GNLY), while NKT cells showed modulated stress-response signatures. Cell-cell communication was reorganized, with the EPHA/NRG pathways highlighting CD4 + TEM, MAIT, and NKT cells as central signaling hubs. Critically, these immunomodulatory changes were quantitatively associated with clinical improvement: reductions in B cell and innate immune subsets correlated with gains in grip strength and gait speed, while regulatory T cell expansion was linked to improved lower-limb function. Conclusions: HUC-MSCs restore immune homeostasis in aging frailty through sequential, multi-faceted immunomodulation. The association between specific immune remodeling features and functional recovery positions HUC-MSCs as a promising mechanism-based therapy for aging frailty.

  • Corrigendum to “SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of CircFARSA expression” [Biomed. Pharmacother. 147 (2022) 112672]

    by Huixiao Yuan, Xin Huang, Qingqing Li, Cici Luo, Chenyu Lin, Shuxian Zhang, Yaguang Zhang, Zhilin Yan, Ning Du, Zhongmin Liu, et al.

  • Open Access

    Effects of a comprehensive management mode for overweight/obesity based on mobile internet technology and traditional Chinese medicine constitution theory: a randomized controlled trial

    by Xin Chen, Junyi Duan, Ruxin Duan, Yixing Wang, Hua Jiang

    Background: We aimed to investigate the overall effectiveness of a comprehensive management mode for overweight/obesity based on mobile internet technology and TCM constitution theory. Methods: 40 subjects were enrolled and randomly divided into control group (traditional obesity management mode) and intervention group (comprehensive obesity management mode). The intervention period was 8 weeks, and the follow-up period was 1 year. The information of body indicators, blood indicators and gut microbiota indicators at baseline, 8 weeks and 1 year were collected and analyzed, the primary outcome was the effective weight loss (≥5% body weight loss) rate at 1 year. Results: The average age of 40 subjects was 40.3 ± 9.49 years old, with 18 males accounting for 45%. The effective weight loss rate of intervention group was significantly higher than control group (75% vs. 35%; p = 0.025) at 1 year. The body weight (6.88 ± 4.00 vs. 3.08 ± 2.35, p = 0.001), BMI(2.38 ± 1.23 vs. 1.10 ± 0.87, p = 0.001), body fat rate(BFR; 1.8 ± 0.85 vs. 0.82 ± 0.60, p = 0.001), fasting plasma glucose (FPG; 1.08 ± 0.69 vs. 0.49 ± 0.91, p = 0.027), total cholesterol (TC; 1.72 ± 0.60 vs. 0.77 ± 0.57, p = 0.001), Triglyceride (TG; 0.56 ± 0.52 vs. 0.16 ± 0.22, p = 0.003), low density lipoprotein cholesterol (LDL-C; 1.35 ± 0.49 vs. 0.71 ± 0.50, p = 0.001), and diastolic blood pressure (DBP; 1.80 ± 1.96 vs. 0.60 ± 1.57, p = 0.039) decreased more significant in the intervention group. The gut microbiota analysis showed that after intervention, in the intervention group, at phylum level, the Cyanobacteria abundance increased ( p = 0.040), while the Euryarchaeota abundance decreased ( p = 0.045). In addition, the functional abundance of Photosynthesis decreased ( p = 0.008). Conclusion: The comprehensive overweight/obesity management mode integrating mHealth with TCM constitution showed more significant long-term weight loss effects. The increase of Cyanobacteria and decrease of Euryarchaeota may be associated with this effect, warranting further investigation. Clinical trial registration: https://www.chictr.org.cn/showproj.html?proj=43245 , Identifier, ChiCTR1900025881.

  • Open Access

    Proactive health behaviour intervention strategies for older T2DM patients with multimorbidity: protocol for a cluster randomised controlled trial with hybrid type 2 effectiveness-implementation design

    by Yang Li, Qian Huang, Jianli Ge, Yue Liu, Shasha Geng, Qingqing Li, Xin Chen, Yingqian Zhu, Xiaotong Guo, Fengyi Lu, et al.

    The increasing prevalence of multimorbidity represents a significant public health challenge, particularly in an ageing global population. This is particul

  • Open Access

    Digital intelligence for cardiometabolic health management in older adults: protocol for a community-based prospective cohort study

    by Yang Li, Fengyi Lu, Qi Wang, Qian Huang, Shengying Ling, Ning Xu, Huai Jiang, Jing Fang, Yue Liu, Liying Huang, et al.

    Cardiovascular diseases (CVDs) represent a significant cause of morbidity and mortality among older adults in China, exerting a substantial influence on their quality of life and life expectancy. The country’s ageing population is predicted to intensify this burden, underscoring the need for the development of innovative and effective management strategies. The prospective cohort study will recruit older patients with cardiometabolic diseases from multiple community health service centres in Shanghai. Participants will be comprehensively assessed for CVD risk factors, medications, functional status, and multi-omics data, along with continuous sign monitoring data from wearable bracelets and their electronic health records. The primary objective of the study is twofold: firstly, to explore the independent and joint predictive power of digital biomarkers and clinical indicators for cardiovascular events (new incident/recurrent), dementia, death and other adverse outcomes in older adults; and secondly, to establish a digital twin platform for precision medicine. The study proposes a novel integration of digital intelligence into cardiometabolic health management for older adults. The utilisation of comprehensive data collection and advanced analytical methods is anticipated to generate valuable insights into the intricate interplay of risk factors and outcomes. The development of personalised risk assessment models and intelligent alert systems has the potential to enhance the prevention and treatment of CVDs, thereby improving health outcomes and quality of life for older adults. ChiCTR2500096478 (Chinese Clinical Trial Registry). Registered 24 January 2025 - Prospectively registered.


  • Top Cited Papers
    Open Access

    Global burden and risk factors of type 2 diabetes mellitus from 1990 to 2021, with forecasts to 2050

    by Qian Huang, Yang Li, Minggang Yu, Zhizi Lv, Fengyi Lu, Ning Xu, Qingqing Zhang, Jiayun Shen, Jinfeng Zhu, Hua Jiang

    Background: Type 2 diabetes mellitus (T2DM) presents a substantial strain on global healthcare systems. This study seeks to offer robust scientific evidence for the effective prevention and management of T2DM globally through a comprehensive analysis of the disease’s burden, trends, and risk factors from 1990 to 2021, as well as future trajectories from 2022 to 2050.Methods: Data for this study were sourced from the 2021 Global Burden of Disease (GBD) study. T2DM burden was assessed through incidence, prevalence, mortality, and disability-adjusted life years (DALYs), stratified by age, sex, sociodemographic index (SDI), 21 GBD regions, and 204 countries/territories. Trends from 1990 to 2021 were quantified by estimating annual percentage changes. Decomposition analysis identified the primary population-level drivers of T2DM burden changes. The population attributable fraction assessed the contribution of risk factors to the T2DM burden over the past 30 years, while the Bayesian age–period–cohort model was employed to predict the future burden driven by risk factors.Results: In 2021, T2DM affected 506.0 million individuals, with 23.9 million new cases, 1.6 million deaths, and 75.3 million DALYs. Between 1990 and 2021, both absolute and relative burdens of T2DM increased, particularly among males, older adults, and individuals under 40. Regions with higher SDI generally exhibited higher age-standardized incidence and prevalence rates, while those with lower SDI had elevated age-standardized mortality and DALY rates. Oceania stood out as an exception, with the highest relative burdens across all four indicators, most notably in the Marshall Islands and Fiji. The increases in incidence, DALYs, and prevalence were predominantly driven by population growth and epidemiological shifts, with aging contributing significantly to the rise in mortality. Elevated fasting plasma glucose, body mass index (BMI), and particulate pollution were major contributors to higher T2DM-related mortality and DALY rates. By 2050, high BMI, alcohol consumption, and sugary beverages are anticipated to increasingly influence the T2DM burden.Conclusion: Focused, preventive interventions targeting key risk factors in high-burden groups can effectively reduce the global T2DM burden.


  • Open Access

    Independent and joint associations of physical activity and a body shape index with sleep disorders in older adults with cardiometabolic multimorbidity: a cross-sectional study

    by Yang Li, Huiqian Zhou, Dandan Xu, Hua Wang, Yutong Zhao, Hua Jiang

    Cardiometabolic multimorbidity (CMM) has become a significant public health challenge in the context of global ageing. Sleep disorders are prevalent in older adults with CMM, but their correlations with physical activity and a body shape index (ABSI) remain unclear. This study aimed to investigate the independent and joint associations of physical activity and ABSI with sleep disorders in older adults with CMM. This cross-sectional study was conducted between February and March 2024 and recruited 650 older CMM patients (aged ≥ 65 years) by random sampling. Data were collected using a structured questionnaire as well as the Pittsburgh Sleep Quality Index (PSQI) and the International Physical Activity Questionnaire-short form (IPAQ-SF). Logistic regression models were used to assess the independent and joint associations of physical activity and ABSI with sleep disorders. The prevalence of sleep disorders among older CMM patients was 48.46%, and low IPAQ (OR = 3.61, 95%CI: 2.41 to 5.43) and high ABSI (OR = 1.46, 95%CI: 1.04 to 2.04) were identified as independent risk factors for sleep disorders. The risk of sleep disorders in patients with low IPAQ and high ABSI group was approximately 5.1 times higher than that in patients with middle/high IPAQ and low ABSI group (OR = 5.10, 95% CI: 2.88 to 9.02). The stratified analyses indicated that these relationships were particularly pronounced in the > 70 years and female subgroups. This study highlights the important impact of physical activity and body shape management on sleep disorders in older CMM patients.